Alfa Chemistry Materials 5 - Products
Alfa Chemistry Materials is specialized in material chemistry and offers an extensive catalog of materials in a wide range of applications, including Metals and Materials, 3D Printing Materials, Biomaterials.
| Product | Description | |
|---|---|---|
| Molecular sieves, -600 mesh powder (Linde 3A) | Sodium aluminosilicate is a fine white powder. Many ordinary rocks (feldspars) are aluminosilicates. Aluminosilicates with more open three-dimensional structures than the feldspars are called zeolites. The openings in zeolites appear as polyhedral cavities connected by tunnels. Zeolites act as catalysts by absorbing small molecules in their interior cavities and holding them in proximity so that reaction among them occurs sooner.;DryPowder; DryPowder, OtherSolid; OtherSolid; PelletsLargeCrystals. Group: Molecular sieve. CAS No. 308080-99-1. Product ID: aluminum; sodium; dioxido(oxo)silane. Molecular formula: 202.14g/mol. Mole weight: AlNaO6Si2. [O-][Si](=O)[O-]. [O-][Si](=O)[O-]. [Na+]. [Al+3]. InChI=1S/Al.Na.2O3Si/c; ; 2*1-4(2)3/q+3; +1; 2*-2. URGAHOPLAPQHLN-UHFFFAOYSA-N. |  |
| Molecular sieves, -600 mesh powder (Linde 4A) | Molecular sieves, -600 mesh powder (Linde 4A). Group: Molecular sieve. CAS No. 70955-01-0. Product ID: (2R,3S)-2-[[(2R)-2-acetamido-3-(3-fluorophenyl)propanoyl]amino]-5-methoxy-4-methoxycarbonyl-3-methyl-5-oxopentanoic acid. Molecular formula: 440.4g/mol. Mole weight: C20H25FN2O8. CC (C (C (=O)OC)C (=O)OC)C (C (=O)O)NC (=O)C (CC1=CC (=CC=C1)F)NC (=O)C. InChI=1S/C20H25FN2O8/c1-10 (15 (19 (28)30-3)20 (29)31-4)16 (18 (26)27)23-17 (25)14 (22-11 (2)24)9-12-6-5-7-13 (21)8-12/h5-8, 10, 14-16H, 9H2, 1-4H3, (H, 22, 24) (H, 23, 25) (H, 26, 27)/t10-, 14+, 16+/m0/s1. FJUZEZRZKVMAMD-DRZCJDIDSA-N. | |
| Molecular sieves, -600 mesh powder (Linde 5A) | Sodium aluminosilicate is a fine white powder. Many ordinary rocks (feldspars) are aluminosilicates. Aluminosilicates with more open three-dimensional structures than the feldspars are called zeolites. The openings in zeolites appear as polyhedral cavities connected by tunnels. Zeolites act as catalysts by absorbing small molecules in their interior cavities and holding them in proximity so that reaction among them occurs sooner.;DryPowder; DryPowder, OtherSolid; OtherSolid; PelletsLargeCrystals. Group: Molecular sieve. CAS No. 69912-79-4. Product ID: aluminum; sodium; dioxido(oxo)silane. Molecular formula: 202.14g/mol. Mole weight: AlNaO6Si2. [O-][Si](=O)[O-]. [O-][Si](=O)[O-]. [Na+]. [Al+3]. InChI=1S/Al.Na.2O3Si/c; ; 2*1-4(2)3/q+3; +1; 2*-2. URGAHOPLAPQHLN-UHFFFAOYSA-N. | |
| Molecular sieves, -8+12 beads (Linde 4A) | Molecular sieves, -8+12 beads (Linde 4A). Group: Molecular sieve. CAS No. 70955-01-0. Product ID: (2R,3S)-2-[[(2R)-2-acetamido-3-(3-fluorophenyl)propanoyl]amino]-5-methoxy-4-methoxycarbonyl-3-methyl-5-oxopentanoic acid. Molecular formula: 440.4g/mol. Mole weight: C20H25FN2O8. CC (C (C (=O)OC)C (=O)OC)C (C (=O)O)NC (=O)C (CC1=CC (=CC=C1)F)NC (=O)C. InChI=1S/C20H25FN2O8/c1-10 (15 (19 (28)30-3)20 (29)31-4)16 (18 (26)27)23-17 (25)14 (22-11 (2)24)9-12-6-5-7-13 (21)8-12/h5-8, 10, 14-16H, 9H2, 1-4H3, (H, 22, 24) (H, 23, 25) (H, 26, 27)/t10-, 14+, 16+/m0/s1. FJUZEZRZKVMAMD-DRZCJDIDSA-N. | |
| Molybdenum disulfide ink for inkjet printing | Curing condition: 400° C, 3 hours in Ar/H2 environment. Uses: Electrocatalyst. field-effect transistors. sensors. lithium ion batteries. supercapacitors. Group: Carbon nano materials printed electronic materials. | |
| Molybdenum disulfide ink for spin/spray coating | Resistivity: 75-100 kΩ·cm (Prepared by spin-coating at 1000 rpm/30 s for 1 coat, followed by thermal annealing at 400°C in Ar/H2 for 3 hours). Uses: N-type semiconductor for use in transistors, photodetectors and photovoltaics. Group: Carbon nano materials printed electronic materials. Alternative Names: MoS2 dispersion,MoS2 ink. Mole weight: MoS2. | |
| Molybdenum Plate Purified 99.9% | Molybdenum Plate Purified 99.9%. Group: Glass additives. | |
| Molybdic Acid | DryPowder. Group: Glass additives. Product ID: dihydroxy(dioxo)molybdenum. Molecular formula: 162g/mol. Mole weight: H2MoO4;H2MoO4. O[Mo](=O)(=O)O. InChI=1S/Mo.2H2O.2O/h; 2*1H2; ; /q+2; ; ; ; /p-2. VLAPMBHFAWRUQP-UHFFFAOYSA-L. | |
| Mono-2-O-(p-toluenesulfonyl)-α-cyclodextrin | Mono-2-O-(p-toluenesulfonyl)-α-cyclodextrin. Group: Supramolecular host materials. CAS No. 93184-10-2. | |
| Mono-2-O-(p-toluenesulfonyl)-β-cyclodextrin Hydrate | Mono-2-O-(p-toluenesulfonyl)-β-cyclodextrin Hydrate. Group: Supramolecular host materials. CAS No. 84216-71-7. Product ID: [(1S, 3R, 5R, 6S, 8R, 10R, 11S, 13R, 15R, 16S, 18R, 20R, 21S, 23R, 25R, 26S, 28R, 30R, 31S, 33R, 35R, 36R, 37R, 38R, 39R, 40S, 41R, 42R, 43R, 44R, 45R, 46R, 47R, 48R, 49R)-36, 37, 38, 39, 40, 42, 43, 44, 45, 46, 47, 48, 49-tridecahydroxy-5, 10, 15, 20, 25, 30, 35-heptakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontan-41-yl] 4-methylbenzenesulfonate. Molecular formula: 1289.2g/mol. Mole weight: C49H76O37S. CC1=CC=C (C=C1)S (=O) (=O)OC2C (C3C (OC2OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (C (C8O)O)OC9C (OC (O3)C (C9O)O)CO)CO)CO)CO)CO)CO)CO)O. InChI=1S/C49H76O37S/c1-13-2-4-14 (5-3-13)87 (70, 71)86-42-34 (69)41-21 (12-56)78-49 (42)85-40-20 (11-55)77-47 (33 (68)27 (40)62)83-38-18 (9-53)75-45 (31 (66)25 (38)60)81-36-16 (7-51)73-43 (29 (64)23 (36)58)79-35-15 (6-50)72-44 (28 (63)22 (35)57)80-37-17 (8-52)74-46 (30 (65)24 (37)59)82-39-19 (10-54)76-48 (84-41)32 (67)26 (39)61/h2-5, 15-69H, 6-12H2, 1H3/t15-, 16-, 17-, 18-, 19-, 20-, 21-, 22-, 23-, 24-, 25-, 26-, 27-, 28-, 29-, 30-, 31-, 32-, 33-, 34+, 35-, 36-, 37-, 38-, 39-, 40-, 41-, 42-, 43-, 44-, 45-, 46-, 47-, 48-, 49-/m1/s1. VGZWDYWXWGKKEE-UJPGXMRNSA-N. | |
| Mono-2-O-(p-toluenesulfonyl)-γ-cyclodextrin | Mono-2-O-(p-toluenesulfonyl)-γ-cyclodextrin. Group: Supramolecular host materials. CAS No. 97227-32-2. Product ID: [(1S, 3R, 5R, 6S, 8R, 10R, 11S, 13R, 15R, 16S, 18R, 20R, 21S, 23R, 25R, 26S, 28R, 30R, 31S, 33R, 35R, 36S, 38R, 40R, 41R, 42R, 43R, 44R, 45R, 46R, 47S, 48R, 49R, 50R, 51R, 52R, 53R, 54R, 55R, 56R)-41, 42, 43, 44, 45, 46, 47, 49, 50, 51, 52, 53, 54, 55, 56-pentadecahydroxy-5, 10, 15, 20, 25, 30, 35, 40-octakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34, 37, 39-hexadecaoxanonacyclo[36.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31.233, 36]hexapentacontan-48-yl] 4-methylbenzenesulfonate. Molecular formula: 1451.3g/mol. Mole weight: C55H86O42S. CC1=CC=C (C=C1)S (=O) (=O)OC2C (C3C (OC2OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (C (C8O)O)OC9C (OC (C (C9O)O)OC1C (OC (O3)C (C1O)O)CO)CO)CO)CO)CO)CO)CO)CO)O. InChI=1S/C55H86O42S/c1-14-2-4-15 (5-3-14)98 (79, 80)97-47-38 (78)46-23 (13-63)88-55 (47)96-45-22 (12-62)87-53 (37 (77)30 (45)70)94-43-20 (10-60)85-51 (35 (75)28 (43)68)92-41-18 (8-58)83-49 (33 (73)26 (41)66)90-39-16 (6-56)81-48 (31 (71)24 (39)64)89-40-17 (7-57)82-50 (32 (72)25 (40)65)91-42-19 (9-59)84-52 (34 (74)27 (42)67)93-44-21 (11-61)86-54 (95-46)36 (76)29 (44)69/h2-5, 16-78H, 6-13H2, 1H3/t16-, 17-, 18-, 19-, 20-, 21-, 22-, 23-, 24-, 25-, 26-, 27-, 28-, 29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, 38+, 39- | |
| Mono-6-O-(2-naphthyl)-per-O-methyl-α-cyclodextrin | Mono-6-O-(2-naphthyl)-per-O-methyl-α-cyclodextrin. Group: Supramolecular host materials. CAS No. 1019999-18-8. Product ID: 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecamethoxy-5, 10, 15, 20, 25-pentakis(methoxymethyl)-30-(naphthalen-2-yloxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontane. Molecular formula: 1337.4g/mol. Mole weight: C63H100O30. COCC1C2C (C (C (O1) OC3C (OC (C (C3OC) OC) OC4C (OC (C (C4OC) OC) OC5C (OC (C (C5OC) OC) OC6C (OC (C (C6OC) OC) OC7C (OC (O2) C (C7OC) OC) COC) COC) COC8=CC9=CC=CC=C9C=C8) COC) COC) OC) OC. InChI=1S / C63H100O30 / c1-64-25-34-40-46 (69-6) 52 (75-12) 58 (82-34) 89-41-35 (26-65-2) 84-60 (54 (77-14) 47 (41) 70-7) 91-43-37 (28-67-4) 86-62 (56 (79-16) 49 (43) 72-9) 93-45-39 (30-81-33-23-22-31-20-18-19-21-32 (31) 24-33) 87-63 (57 (80-17) 51 (45) 74-11) 92-44-38 (29-68-5) 85-61 (55 (78-15) 50 (44) 73-10) 90-42-36 (27-66-3) 83-59 (88-40) 53 (76-13) 48 (42) 71-8 / h18-24, 34-63H, 25-30H2, 1-17H3. XRGIJNKZLAFOQY-UHFFFAOYSA-N. | |
| Mono-6-O-(2-naphthyl)-per-O-methyl-alpha-cyclodextrin | Mono-6-O-(2-naphthyl)-per-O-methyl-alpha-cyclodextrin. Group: Macrocycles. CAS No. 1019999-18-8. Product ID: 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecamethoxy-5, 10, 15, 20, 25-pentakis(methoxymethyl)-30-(naphthalen-2-yloxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontane. Molecular formula: 1337.4g/mol. Mole weight: C63H100O30. COCC1C2C (C (C (O1) OC3C (OC (C (C3OC) OC) OC4C (OC (C (C4OC) OC) OC5C (OC (C (C5OC) OC) OC6C (OC (C (C6OC) OC) OC7C (OC (O2) C (C7OC) OC) COC) COC) COC8=CC9=CC=CC=C9C=C8) COC) COC) OC) OC. InChI=1S / C63H100O30 / c1-64-25-34-40-46 (69-6) 52 (75-12) 58 (82-34) 89-41-35 (26-65-2) 84-60 (54 (77-14) 47 (41) 70-7) 91-43-37 (28-67-4) 86-62 (56 (79-16) 49 (43) 72-9) 93-45-39 (30-81-33-23-22-31-20-18-19-21-32 (31) 24-33) 87-63 (57 (80-17) 51 (45) 74-11) 92-44-38 (29-68-5) 85-61 (55 (78-15) 50 (44) 73-10) 90-42-36 (27-66-3) 83-59 (88-40) 53 (76-13) 48 (42) 71-8 / h18-24, 34-63H, 25-30H2, 1-17H3. XRGIJNKZLAFOQY-UHFFFAOYSA-N. | |
| Mono-6-O-mesitylenesulfonyl-γ -cyclodextrin | Mono-6-O-mesitylenesulfonyl-γ -cyclodextrin. Group: Supramolecular host materials. CAS No. 174010-62-9. Product ID: [41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56-hexadecahydroxy-5, 10, 15, 25, 30, 35, 40-heptakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34, 37, 39-hexadecaoxanonacyclo[36.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31.233, 36]hexapentacontan-20-yl]methyl 2,4,6-trimethylbenzenesulfonate. Molecular formula: 1479.4g/mol. Mole weight: C57H90O42S. CC1=CC (=C (C (=C1)C)S (=O) (=O)OCC2C3C (C (C (O2)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (C (C8O)O)OC9C (OC (C (C9O)O)OC1C (OC (O3)C (C1O)O)CO)CO)CO)CO)CO)CO)CO)O)O)C. InChI=1S/C57H90O42S/c1-14-4-15 (2)49 (16 (3)5-14)100 (81, 82)83-13-24-48-32 (72)40 (80)57 (91-24)98-47-23 (12-64)89-55 (38 (78)30 (47)70)96-45-21 (10-62)87-53 (36 (76)28 (45)68)94-43-19 (8-60)85-51 (34 (74)26 (43)66)92-41-17 (6-58)84-50 (33 (73)25 (41)65)93-42-18 (7-59)86-52 (35 (75)27 (42)67)95-44-20 (9-61)88-54 (37 (77)29 (44)69)97-46-22 (11-63)90-56 (99-48)39 (79)31 (46)71/h4-5, 17-48, 50-80H, 6-13H2, 1-3H3. JINRRYVZBGTIER-UHFFFAOYSA-N. | |
| Mono-6-O-mesitylenesulfonyl-gamma-cyclodextrin | Mono-6-O-mesitylenesulfonyl-gamma-cyclodextrin. Group: Macrocycles. CAS No. 174010-62-9. Product ID: [41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56-hexadecahydroxy-5, 10, 15, 25, 30, 35, 40-heptakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34, 37, 39-hexadecaoxanonacyclo[36.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31.233, 36]hexapentacontan-20-yl]methyl 2,4,6-trimethylbenzenesulfonate. Molecular formula: 1479.4g/mol. Mole weight: C57H90O42S. CC1=CC (=C (C (=C1)C)S (=O) (=O)OCC2C3C (C (C (O2)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (C (C8O)O)OC9C (OC (C (C9O)O)OC1C (OC (O3)C (C1O)O)CO)CO)CO)CO)CO)CO)CO)O)O)C. InChI=1S/C57H90O42S/c1-14-4-15 (2)49 (16 (3)5-14)100 (81, 82)83-13-24-48-32 (72)40 (80)57 (91-24)98-47-23 (12-64)89-55 (38 (78)30 (47)70)96-45-21 (10-62)87-53 (36 (76)28 (45)68)94-43-19 (8-60)85-51 (34 (74)26 (43)66)92-41-17 (6-58)84-50 (33 (73)25 (41)65)93-42-18 (7-59)86-52 (35 (75)27 (42)67)95-44-20 (9-61)88-54 (37 (77)29 (44)69)97-46-22 (11-63)90-56 (99-48)39 (79)31 (46)71/h4-5, 17-48, 50-80H, 6-13H2, 1-3H3. JINRRYVZBGTIER-UHFFFAOYSA-N. | |
| Mono-6-O-(p-toluenesulfonyl)-α-cyclodextrin | Mono-6-O-(p-toluenesulfonyl)-α-cyclodextrin. Group: Supramolecular host materials. CAS No. 32860-56-3. Product ID: [(1S, 3R, 6S, 8R, 11S, 13R, 16S, 18R, 21S, 23R, 26S, 28R, 32S, 34S, 36S, 38S, 40S, 42S)-31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecahydroxy-10, 15, 20, 25, 30-pentakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontan-5-yl]methyl 4-methylbenzenesulfonate. Molecular formula: 1127g/mol. Mole weight: C43H66O32S. CC1=CC=C (C=C1)S (=O) (=O)OCC2C3C (C (C (O2)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (O3)C (C8O)O)CO)CO)CO)CO)CO)O)O. InChI=1S/C43H66O32S/c1-12-2-4-13 (5-3-12)76 (61, 62)63-11-19-37-25 (54)31 (60)43 (69-19)74-36-18 (10-48)67-41 (29 (58)23 (36)52)72-34-16 (8-46)65-39 (27 (56)21 (34)50)70-32-14 (6-44)64-38 (26 (55)20 (32)49)71-33-15 (7-45)66-40 (28 (57)22 (33)51)73-35-17 (9-47)68-42 (75-37)30 (59)24 (35)53/h2-5, 14-60H, 6-11H2, 1H3/t14?, 15?, 16?, 17?, 18?, 19?, 20?, 21?, 22?, 23?, 24?, 25?, 26-, 27-, 28-, 29-, 30-, 31-, 32+, 33+, 34+, 35+, 36+, 37+, 38+, 39+, 40+, 41+, 42+, 43+/m0/s1. ARQITQMHQNGIEE-FJFUKXEISA-N. | |
| Mono-6-O-(p-toluenesulfonyl)-β-cyclodextrin | Mono-6-O-(p-toluenesulfonyl)-β-cyclodextrin. Group: Supramolecular host materials. CAS No. 67217-55-4. Product ID: [(1S, 3R, 5R, 6S, 8R, 10R, 11S, 13R, 15R, 16S, 18R, 20R, 21S, 23R, 25R, 26S, 28R, 30R, 31S, 33R, 35R, 36R, 37R, 38R, 39R, 40R, 41R, 42R, 43R, 44R, 45R, 46R, 47R, 48R, 49R)-36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49-tetradecahydroxy-5, 15, 20, 25, 30, 35-hexakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontan-10-yl]methyl 4-methylbenzenesulfonate. Molecular formula: 1289.2g/mol. Mole weight: C49H76O37S. CC1=CC=C (C=C1)S (=O) (=O)OCC2C3C (C (C (O2)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (C (C8O)O)OC9C (OC (O3)C (C9O)O)CO)CO)CO)CO)CO)CO)O)O. InChI=1S/C49H76O37S/c1-13-2-4-14 (5-3-13)87 (70, 71)72-12-21-42-28 (62)35 (69)49 (79-21)85-41-20 (11-55)77-47 (33 (67)26 (41)60)83-39-18 (9-53)75-45 (31 (65)24 (39)58)81-37-16 (7-51)73-43 (29 (63)22 (37)56)80-36-15 (6-50)74-44 (30 (64)23 (36)57)82-38-17 (8-52)76-46 (32 (66)25 (38)59)84-40-19 (10-54)78-48 (86-42)34 (68)27 (40)61/h2-5, 15-69H, 6-12H2, 1H3/t15-, 16-, 17-, 18-, 19-, 20-, 21-, 22-, 23-, 24-, 25-, 26-, 27-, 28-, 29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, 38-, 39-, 40-, 41-, 42-, 43-, 44-, 45-, 46-, 47-, 48-, 49-/m1/s1. URYLJCBFCXEADB-XISQNVKBSA-N. | |
| Mono-6-O-(p-toluenesulfonyl)-γ-cyclodextrin | Mono-6-O-(p-toluenesulfonyl)-γ-cyclodextrin. Group: Supramolecular host materials. CAS No. 97227-33-3. Product ID: [(1S, 3R, 5R, 6S, 8R, 10R, 11S, 13R, 15R, 16S, 18R, 20R, 21S, 23R, 25R, 26S, 28R, 30R, 31S, 33R, 35R, 36S, 38R, 40R, 41R, 42R, 43R, 44R, 45R, 46R, 47R, 48R, 49R, 50R, 51R, 52R, 53R, 54R, 55R, 56R)-41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56-hexadecahydroxy-5, 10, 15, 25, 30, 35, 40-heptakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34, 37, 39-hexadecaoxanonacyclo[36.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31.233, 36]hexapentacontan-20-yl]methyl 4-methylbenzenesulfonate. Molecular formula: 1451.3g/mol. Mole weight: C55H86O42S. CC1=CC=C (C=C1)S (=O) (=O)OCC2C3C (C (C (O2)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (C (C8O)O)OC9C (OC (C (C9O)O)OC1C (OC (O3)C (C1O)O)CO)CO)CO)CO)CO)CO)CO)O)O. InChI=1S/C55H86O42S/c1-14-2-4-15 (5-3-14)98 (79, 80)81-13-23-47-31 (70)39 (78)55 (89-23)96-46-22 (12-62)87-53 (37 (76)29 (46)68)94-44-20 (10-60)85-51 (35 (74)27 (44)66)92-42-18 (8-58)83-49 (33 (72)25 (42)64)90-40-16 (6-56)82-48 (32 (71)24 (40)63)91-41-17 (7-57)84-50 (34 (73)26 (41)65)93-43-19 (9-59)86-52 (36 (75)28 (43)67)95-45-21 (11-61)88-54 (97-47)38 (77)30 (45)69/h2-5, 16-78H, 6-13H2, 1H3/t16-, 17-, 18-, 19-, 20-, 21-, 22-, 23-, 24-, 25-, 26-, 27-, 28-, 29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, | |
| Mono-6-O-(p-toluenesulfonyl)-gamma-cyclodextrin | Mono-6-O-(p-toluenesulfonyl)-gamma-cyclodextrin. Group: Macrocycles. CAS No. 97227-33-3. Product ID: [(1S, 3R, 5R, 6S, 8R, 10R, 11S, 13R, 15R, 16S, 18R, 20R, 21S, 23R, 25R, 26S, 28R, 30R, 31S, 33R, 35R, 36S, 38R, 40R, 41R, 42R, 43R, 44R, 45R, 46R, 47R, 48R, 49R, 50R, 51R, 52R, 53R, 54R, 55R, 56R)-41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56-hexadecahydroxy-5, 10, 15, 25, 30, 35, 40-heptakis(hydroxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34, 37, 39-hexadecaoxanonacyclo[36.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31.233, 36]hexapentacontan-20-yl]methyl 4-methylbenzenesulfonate. Molecular formula: 1451.3g/mol. Mole weight: C55H86O42S. CC1=CC=C (C=C1)S (=O) (=O)OCC2C3C (C (C (O2)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (C (C8O)O)OC9C (OC (C (C9O)O)OC1C (OC (O3)C (C1O)O)CO)CO)CO)CO)CO)CO)CO)O)O. InChI=1S/C55H86O42S/c1-14-2-4-15 (5-3-14)98 (79, 80)81-13-23-47-31 (70)39 (78)55 (89-23)96-46-22 (12-62)87-53 (37 (76)29 (46)68)94-44-20 (10-60)85-51 (35 (74)27 (44)66)92-42-18 (8-58)83-49 (33 (72)25 (42)64)90-40-16 (6-56)82-48 (32 (71)24 (40)63)91-41-17 (7-57)84-50 (34 (73)26 (41)65)93-43-19 (9-59)86-52 (36 (75)28 (43)67)95-45-21 (11-61)88-54 (97-47)38 (77)30 (45)69/h2-5, 16-78H, 6-13H2, 1H3/t16-, 17-, 18-, 19-, 20-, 21-, 22-, 23-, 24-, 25-, 26-, 27-, 28-, 29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, 38-, 39-, 40-, 41-, 4 | |
| Monocrystalline Diamond | Monocrystalline Diamond. Group: Nanoparticles. | |
| Monocrystalline Diamond | Carbon black oil appears as a dark colored liquid with a petroleum-like odor. Less dense than water and insoluble in water. Vapors heavier than air.;Carbon, activated is a black grains that have been treated to improve absorptive ability. May heat spontaneously if not properly cooled after manufacture.;Carbon, animal or vegetable origin appears as a black powder or granular mixed with a tar or starch and water binder pressed into regular lumps or briquettes. Heats slowly and ignites in air especially if wet.;Graphite (natural) appears as a mineral form of the element carbon. Hexagonal crystals or thin leaf-like layers. Steel-gray to black with a metallic luster and a greasy feel. An electrical conductor. Used for high-temperature crucibles, as a lubricant and in "lead" pencils.;DryPowder; DryPowder, Liquid; DryPowder, PelletsLargeCrystals; DryPowder, PelletsLargeCrystals, WetSolid, OtherSolid, Liquid; DryPowder, WetSolid, Liquid; Liquid; OtherSolid; OtherSolid, GasVapor, Liquid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid, Liquid; WetSolid; WetSolid, Liquid;OtherSolid; PelletsLargeCrystals;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid; WetSolid;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; DryPowder, WetSolid; Liquid; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid; WetSolid;Bl | |
| Monodispersed Magnetite Microspheres | Monodispersed Magnetite Microspheres. Group: Poss nanohybrid materials. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 100-200 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 100-200 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 100-200 nm avg. part. size, Carboxyl functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 100-200 nm avg. part. size, Carboxyl functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 100-200 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 100-200 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 10-30nm avg. part. size, amine functionalized, 25% Fe3O4 dispersion in H2O | Monodispersed magnetite microspheres, 10-30nm avg. part. size, amine functionalized, 25% Fe3O4 dispersion in H2O. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 200-300 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 200-300 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 200-300 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 200-300 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 200-300 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 200-300 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 300-400 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 300-400 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 300-400 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 300-400 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 300-400 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 300-400 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 400-500 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 400-500 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 400-500 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 400-500 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 400-500 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 400-500 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 500-600 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 500-600 nm avg. part. size, amine functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 500-600 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 500-600 nm avg. part. size, -Epoxy functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodispersed magnetite microspheres, 500-600 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS | Monodispersed magnetite microspheres, 500-600 nm avg. part. size, -SiOH functionalized, 5 mg/mL Fe3O4 dispersion in PBS. Group: Nanopowders. CAS No. 1317-61-9. | |
| Monodisperse Gold Nanoparticles (AU05) | Gold-coloured powder or tiny sheets;Soft yellow metal; gold-colored powder or tiny sheets. Group: Nanodispersions. CAS No. 7440-57-5. Product ID: gold. Molecular formula: 196.96657g/mol. Mole weight: Au;Au. [Au]. InChI=1S/Au. PCHJSUWPFVWCPO-UHFFFAOYSA-N. | |
| Monodisperse Gold Nanoparticles (AU10) | Gold-coloured powder or tiny sheets;Soft yellow metal; gold-colored powder or tiny sheets. Group: Nanodispersions. CAS No. 7440-57-5. Product ID: gold. Molecular formula: 196.96657g/mol. Mole weight: Au;Au. [Au]. InChI=1S/Au. PCHJSUWPFVWCPO-UHFFFAOYSA-N. | |
| Monodisperse Gold Nanoparticles (AU20) | Gold-coloured powder or tiny sheets;Soft yellow metal; gold-colored powder or tiny sheets. Group: Nanodispersions. CAS No. 7440-57-5. Product ID: gold. Molecular formula: 196.96657g/mol. Mole weight: Au;Au. [Au]. InChI=1S/Au. PCHJSUWPFVWCPO-UHFFFAOYSA-N. | |
| Monodisperse Gold Nanoparticles (AU40) | Gold-coloured powder or tiny sheets;Soft yellow metal; gold-colored powder or tiny sheets. Group: Nanodispersions. CAS No. 7440-57-5. Product ID: gold. Molecular formula: 196.96657g/mol. Mole weight: Au;Au. [Au]. InChI=1S/Au. PCHJSUWPFVWCPO-UHFFFAOYSA-N. | |
| Monodisperse Gold Nanoparticles (AU60) | Gold-coloured powder or tiny sheets;Soft yellow metal; gold-colored powder or tiny sheets. Group: Nanodispersions. CAS No. 7440-57-5. Product ID: gold. Molecular formula: 196.96657g/mol. Mole weight: Au;Au. [Au]. InChI=1S/Au. PCHJSUWPFVWCPO-UHFFFAOYSA-N. | |
| Monolayer graphene film | Graphene filmGrowth Method: CVD synthesisTransfer Method: Clean transfer methodQuality Control: Optical Microscopy & Raman checkedSize: 1 cm x 1 cmAppearance (Color): TransparentTransparency: >97%Appearance (Form): FilmCoverage: >95%Number of graphene layers: 1Thickness (theoretical): 0.345 nmFET Electron Mobility on Al2O3: 2; 000 cm2 /V·sFET Electron Mobility on SiO2/Si (expected): 4; 000 cm2 /V·sSheet Resistance: 600 Ohms/sq.Grain size: Up to 10 μmSubstrateSize: 1.25 cm x 1.25 cmType/Dopant: P/BOrientation: 100Growth Method: CZResistivity: 1-30 ohmcmThickness: 525 +/- 25μmFront Surface: polishedBack Surface: etchedCoating: 300 nm thermal oxide on both wafer sides. Uses: Graphene may be extensively incorporated in several applications, such as; nanoelectronics, fuel cells, solar cell, photovoltaic devices, in biosensing, optical biosensors, mems, nems, field effect transistors (fets), chemical sensors, nanocarriers in biosensing assays. Group: Carbon nano materials. | |
| Monolayer Graphene on Cu (10 mm x 10 mm) | Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane, refrigerated liquid (cryogenic liquid) is a colorless odorless liquid. Flammable. Water insoluble.;Natural gas, refrigerated liquid (cryogenic liquid) appears as a flammable liquefied gaseous mixture of straight chain hydrocarbons, predominately methane.;Natural gas, [compressed] appears as a flammable gaseous mixture of straight chain hydrocarbons, predominately compressed methane.;GasVapor; Liquid;Liquid;COLOURLESS ODOURLESS COMPRESSED OR LIQUEFIED GAS. Group: Graphenes. CAS No. 1034343-98-0. Product ID: methane. Molecular formula: 16.043g/mol. Mole weight: CH4;CH4;CH4. C. InChI=1S/CH4/h1H4. VNWKTOKETHGBQD-UHFFFAOYSA-N. | |
| Monolayer Graphene on Cu (60 mm x 40 mm) | Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane, refrigerated liquid (cryogenic liquid) is a colorless odorless liquid. Flammable. Water insoluble.;Natural gas, refrigerated liquid (cryogenic liquid) appears as a flammable liquefied gaseous mixture of straight chain hydrocarbons, predominately methane.;Natural gas, [compressed] appears as a flammable gaseous mixture of straight chain hydrocarbons, predominately compressed methane.;GasVapor; Liquid;Liquid;COLOURLESS ODOURLESS COMPRESSED OR LIQUEFIED GAS. Group: Graphenes. CAS No. 1034343-98-0. Product ID: methane. Molecular formula: 16.043g/mol. Mole weight: CH4;CH4;CH4. C. InChI=1S/CH4/h1H4. VNWKTOKETHGBQD-UHFFFAOYSA-N. | |
| Monolayer Graphene on Cu with PMMA coating (60mm x 40mm) | Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane, refrigerated liquid (cryogenic liquid) is a colorless odorless liquid. Flammable. Water insoluble.;Natural gas, refrigerated liquid (cryogenic liquid) appears as a flammable liquefied gaseous mixture of straight chain hydrocarbons, predominately methane.;Natural gas, [compressed] appears as a flammable gaseous mixture of straight chain hydrocarbons, predominately compressed methane.;GasVapor; Liquid;Liquid;COLOURLESS ODOURLESS COMPRESSED OR LIQUEFIED GAS. Group: Graphenes. CAS No. 1034343-98-0. Product ID: methane. Molecular formula: 16.043g/mol. Mole weight: CH4;CH4;CH4. C. InChI=1S/CH4/h1H4. VNWKTOKETHGBQD-UHFFFAOYSA-N. | |
| Monolayer Graphene on SiO2/Si (10mm x 10mm) | Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane is a colorless odorless gas. It is also known as marsh gas or methyl hydride. It is easily ignited. The vapors are lighter than air. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. It is used in making other chemicals and as a constituent of the fuel, natural gas.;Methane, refrigerated liquid (cryogenic liquid) is a colorless odorless liquid. Flammable. Water insoluble.;Natural gas, refrigerated liquid (cryogenic liquid) appears as a flammable liquefied gaseous mixture of straight chain hydrocarbons, predominately methane.;Natural gas, [compressed] appears as a flammable gaseous mixture of straight chain hydrocarbons, predominately compressed methane.;GasVapor; Liquid;Liquid;COLOURLESS ODOURLESS COMPRESSED OR LIQUEFIED GAS. Group: Graphenes. CAS No. 1034343-98-0. Product ID: methane. Molecular formula: 16.043g/mol. Mole weight: CH4;CH4;CH4. C. InChI=1S/CH4/h1H4. VNWKTOKETHGBQD-UHFFFAOYSA-N. | |
| mPEG10K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Propionaldehyde, mPEG-ALD, Methoxy-PEG-Propionaldehyde. Molecular formula: average Mn 10000. | |
| mPEG10K-Succinimidyl Carboxymethyl Ester | Methoxy PEG NHS Ester (SCM PEG). Amine reactive PEG towards the amino groups of lysine(s) on proteins or other biologics; reaction occurs at room temperature in <1hr at pH 7-8. Stable linker between PEG and NHS ester. Uses: S may include: bioconjugation, drug delivery, peg hydrogel, crosslinker, and surface functionalization. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 10000. | |
| mPEG12-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG12-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 12000. | |
| mPEG12-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanamine. Molecular formula: 559.7g/mol. Mole weight: C25H53NO12. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC CN. InChI= 1S / C25H53NO12 / c1-27-4-5-29-8-9-31-12-13-33-16-17-35 -20-21-37-24-25-38-23-22-36-19-18-34- 15-14-32-11-10-30-7-6-28-3-2-26 / h2-26H | |
| mPEG12-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Methoxy-PEG12-Hydroxyl. Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanol. Molecular formula: 560.7g/mol. Mole weight: C25H52O13. [H]OCCOC. 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. XNWFRZJHXBZDAG-UHFFFAOYSA-N. | |
| mPEG12-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG12-PA, methoxy-PEG-Propionic acid. OC(CCOCCOC)=O. 1S/C6H12O4/c1-9-4-5-10-3-2-6 (7)8/h2-5H2, 1H3, (H, 7, 8). KWMXBFIAGYXCCC-UHFFFAOYSA-N. | |
| mPEG12-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanethiol. Molecular formula: 576.7g/mol. Mole weight: C25H52O12S. COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC CS. InChI= 1S / C25H52O12S / c1-26-2-3-27-4-5-28-6-7-29-8-9-30-10- 11-31-12-13-32-14-15-33-16-17-34-18-1 9-35-20-21-36-22-23-37-24-25-38 / h38H, | |
| mPEG20K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 20000. | |
| mPEG20K-Silane | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| mPEG20K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 20000. | |
| mPEG2K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 2000. | |
| mPEG2K-Thioctic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 2000. | |
| mPEG30K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 30000. | |
| mPEG40K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| mPEG40K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 40000. | |
| mPEG5-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG5-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| mPEG5K-Alkyne | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Alkyne, Methoxy-PEG-Alkyne. Molecular formula: average Mn 5000. | |
| mPEG5K-Hydrazide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Methoxy-PEG-HZ, mPEG-Hydrazide. Molecular formula: average Mn 5000. | |
| mPEG5K-Isocyanate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Isocyanate. Molecular formula: average Mn 5000. | |
| mPEG5K-Phosphate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.